The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.


Updates from The Motley Fool

Latest updates on Mylan from Fool.com.


Stock Performance

MYL vs. S&P 500 | 2 Year Performance
View Interactive MYL Charts
Sponsored by

Key Data Points

Primary metrics and data points about Mylan.
Current Price: $43.15
Prev Close: $45.62
Open: $45.50
Bid: $43.17
Ask: $43.18
Day's Range: $42.78 - $45.99
52wk Range: $37.59 - $55.50
Volume: 17,903,455
Avg Vol 4,748,652
Market Cap: $21.22B
P/E (ttm): 28.51
EPS (ttm): $1.60
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Mylan.
CAPS Rating 4 out of 5
 
654 Outperform
43 Underperform
CAPS All Stars
 
155 Outperform
5 Underperform

How do you think Mylan will perform against the market?



You pick for Mylan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Heather Bresch, CEO

84% Approve

Based on 68 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Mylan.

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers